These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 14695222)
1. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222 [TBL] [Abstract][Full Text] [Related]
2. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991 [TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391 [TBL] [Abstract][Full Text] [Related]
4. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids. Shaw JL; Grass L; Sotiropoulou G; Diamandis EP Clin Biochem; 2007 Jan; 40(1-2):104-10. PubMed ID: 17045982 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357 [TBL] [Abstract][Full Text] [Related]
6. Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker. Scorilas A; Borgoño CA; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP J Clin Oncol; 2004 Feb; 22(4):678-85. PubMed ID: 14966091 [TBL] [Abstract][Full Text] [Related]
7. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Kishi T; Grass L; Soosaipillai A; Scorilas A; Harbeck N; Schmalfeldt B; Dorn J; Mysliwiec M; Schmitt M; Diamandis EP Cancer Res; 2003 Jun; 63(11):2771-4. PubMed ID: 12782581 [TBL] [Abstract][Full Text] [Related]
8. Enzymatic profiling of human kallikrein 14 using phage-display substrate technology. Felber LM; Borgoño CA; Cloutier SM; Kündig C; Kishi T; Ribeiro Chagas J; Jichlinski P; Gygi CM; Leisinger HJ; Diamandis EP; Deperthes D Biol Chem; 2005 Mar; 386(3):291-8. PubMed ID: 15843175 [TBL] [Abstract][Full Text] [Related]
9. Human tissue kallikrein gene family: applications in cancer. Obiezu CV; Diamandis EP Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097 [TBL] [Abstract][Full Text] [Related]
10. B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Simon I; Zhuo S; Corral L; Diamandis EP; Sarno MJ; Wolfert RL; Kim NW Cancer Res; 2006 Feb; 66(3):1570-5. PubMed ID: 16452214 [TBL] [Abstract][Full Text] [Related]
11. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Paliouras M; Diamandis EP Breast Cancer Res Treat; 2007 Mar; 102(1):7-18. PubMed ID: 16897430 [TBL] [Abstract][Full Text] [Related]
12. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Luo LY; Grass L; Howarth DJ; Thibault P; Ong H; Diamandis EP Clin Chem; 2001 Feb; 47(2):237-46. PubMed ID: 11159772 [TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 10 ELISA development and validation in breast cancer sera. Ewan King L; Li X; Cheikh Saad Bouh K; Pedneault M; Chu CW Clin Biochem; 2007 Sep; 40(13-14):1057-62. PubMed ID: 17585892 [TBL] [Abstract][Full Text] [Related]
14. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Luo LY; Katsaros D; Scorilas A; Fracchioli S; Bellino R; van Gramberen M; de Bruijn H; Henrik A; Stenman UH; Massobrio M; van der Zee AG; Vergote I; Diamandis EP Cancer Res; 2003 Feb; 63(4):807-11. PubMed ID: 12591730 [TBL] [Abstract][Full Text] [Related]
15. Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay. Kapadia C; Chang A; Sotiropoulou G; Yousef GM; Grass L; Soosaipillai A; Xing X; Howarth DH; Diamandis EP Clin Chem; 2003 Jan; 49(1):77-86. PubMed ID: 12507963 [TBL] [Abstract][Full Text] [Related]
16. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues. Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496 [TBL] [Abstract][Full Text] [Related]
17. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Borgoño CA; Kishi T; Scorilas A; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M; Diamandis EP Clin Cancer Res; 2006 Mar; 12(5):1487-93. PubMed ID: 16533772 [TBL] [Abstract][Full Text] [Related]
18. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies. Memari N; Grass L; Nakamura T; Karakucuk I; Diamandis EP Biol Chem; 2006 Jun; 387(6):733-40. PubMed ID: 16800734 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Luo LY; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais IA; Howarth DJ; Diamandis EP Clin Cancer Res; 2001 Aug; 7(8):2372-9. PubMed ID: 11489815 [TBL] [Abstract][Full Text] [Related]